BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering
09:30 EDT 17 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it
has received a commitment from an institutional investor to purchase
$3,475,000 of securities in a registered direct offering. BioSante
expects to receive net...
Other Sources for this Article
For Investors:
The Trout Group LLC
Tricia Swanson
(646)
378-2953
tswanson@troutgroup.com
or
For
Media:
McKinney/Chicago
Alan Zachary
312-506-5220
azachary@harrisdmckinney.com
More From BioPortfolio on "BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
